BEGHINI, ALESSANDRO
BEGHINI, ALESSANDRO
Dipartimento di Scienze della Salute
Impact of the germline SH2B3 RS111340708 splicing variant on clinical outcomes and signaling deregulation in core binding factor acute myeloid leukemia
2026 A. Beghini, M. Rachele Stefanucci, L. Leuzzi, D. Bernasconi, L. Cimaschi, A. Trojani, L. Del Castello, R. Cairoli
Efficacy of Midostaurin Combined with Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial
2025 R. Cairoli, A. Gatti, G. Grillo, M.R. Stefanucci, B. Di Camillo, M. Fumagalli, M. Krampera, G. Nadali, I.P. Zappasod, E. Borlenghi, E. Todisco, M. Ubezio, M. Bernardi, A. Molteni, C. Basilico, M. Turrini, R. Greco, V. Mancini, M. Riva, D.P. Bernasconi, B. Brando, S.M. Veronese, A. Beghini
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects
2025 A. Trojani, E. Pungolino, B. Di Camillo, L.E. Bossi, C. Palumbo, M. D'Adda, A. Perego, M. Turrini, C. Elena, L.M. Borin, A. Iurlo, S. Malato, F. Spina, M.L. Latargia, P. Spedini, S. Artale, M. Anghilieri, M.C. Carraro, C. Bucelli, A. Beghini, R. Cairoli
Carbonic Anhydrase 9: mastering ferropoptosis resistance in cancer, protector or weak point?
2024 S. Lombardo, A. Beghini
Beyond the Warburg Effect: KRAS/MAPK-Driven Uridine Utilization in Glucose-Deprived Pancreatic Ductal Adenocarcinoma
2024 E. Mambrin, A. Beghini
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
2024 A. Trojani, A. Beghini, L.M. Bossi, M.R. Stefanucci, C. Palumbo, A. Greco, A. Frustaci, B. Di Camillo, R. Cairoli
Bloom syndrome
2023 A. Beghini
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC
2023 N. Abazari, M.R. Stefanucci, L.E. Bossi, A. Trojani, R. Cairoli, A. Beghini
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
2023 A. Trojani, A. Beghini, L.E.E. Bossi, M.R. Stefanucci, C. Palumbo, A. Greco, A. Frustaci, B. Di Camillo, M. Montillo, R. Cairoli
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting
2023 L. Emanuele Bossi, C. Palumbo, A. Trojani, A. Melluso, B. Di Camillo, A. Beghini, L. Maria Sarnataro, R. Cairoli
A novel start‐loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms
2022 A. Beghini, L. Leuzzi, N. Abazari, L.E. Bossi, V. Guido, A. Trojani, R. Cairoli
Genetic Landscape and Clonal Evolution Patterns of CEBPA-Mutated Acute Myeloid Leukaemia Based on NextGeneration Sequencing: A Retrospective Analysis
2021 L. Leuzzi, V. Mancini, S. Veronese, L. Pezzetti, V. Motta, M. Nichelatti, R. Greco, G. Bertani, M. Montillo, A. Beghini, R. Cairoli
FZD6 triggers Wnt-signalling driven by WNT10BIVS1 expression and highlights new targets in T cell acute lymphoblastic leukemia
2021 A. Cassaro, G. Grillo, M. Notaro, J. Gliozzo, I. Esposito, G. Reda, A. Trojani, G. Valentini, B. Di Camillo, R. Cairoli, A. Beghini
Common Gene Expression Signature of B-Cells of Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathies of Undetermined Significance (IgM MGUS) Compared to Healthy Subjects
2021 A. Trojani, B. Di Camillo, L. Bossi, A. Greco, L. Leuzzi, A. Tedeschi, A. Frustaci, M. Deodato, G. Zamprogna, A. Melluso, A. Panzeri, M. Montillo, A. Beghini, R. Cairoli
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells
2021 A. Trojani, B. Di Camillo, L.E. Bossi, L. Leuzzi, A. Greco, A. Tedeschi, A.M. Frustaci, M. Deodato, G. Zamprogna, A. Beghini, R. Cairoli
CSNK2A2 (casein kinase 2 alpha 2)
2020 N. Abazari, A. Beghini
Prospective Evaluation of a Continuation Therapy with Midostaurin in Adult Patients with Core-Binding Factor Leukemia and Integrated Genetic Analysis: A Multi Center Phase II Study. Preliminary Results
2020 R. Cairoli, M. Krampera, P. Zappasodi, E. Todisco, E. Borlenghi, A. Molteni, M. Fumagalli, M. Ubezio, M. Bernardi, R. Greco, E. Ravelli, V. Mancini, G. Grillo, M. Riva, B. De Marco, A. Cassaro, B. Brando, A. Gatti, S. Veronese, A. Beghini
FZD6 (Frizzled class receptor 6)
2019 A. Beghini, G. Postorino
Targeting WNT10B-Driven Signalling through Induction of FZD6 By Porcupine Inhibition in T Cell Acute Lymphoblastic Leukemia
2019 A. Cassaro, F. Lazzaroni, G. Grillo, G. Reda, R. Cairoli, A. Beghini
Core Binding Factor Leukemia : Chromatin Remodeling Moves Towards Oncogenic Transcription
2019 A. Beghini